Applied Clinical Research, Clinical Trials and Regulatory Affairs
Volume 7, 3 Issues, 2020
ISSN: 2213-4778 (Online)
ISSN: 2213-476X (Print)
This journal supports open access
ISSN: 2213-4778 (Online)
ISSN: 2213-476X (Print)
This journal supports open access
Contents
Applied Clinical Research, Clinical Trials and Regulatory Affairs, Volume 2 - Number 3
Editorial
Pharma Emerging Market’s Scaning by Look and Feel of its Opportunities and Challenges
, 2(3): 115 - 122Parveen Kumar, Swagat Tripathy and Harish Dureja
DOI: 10.2174/2213476X03666151125220257
Comparative Account of Quality Management and Regulatory Aspects of Products with Health Claims: Existing Approaches and Future Challenges for Probiotics and Herbal Products
, 2(3): 123 - 132Malika Arora and Ashish Baldi
DOI: 10.2174/2213476X02666151103213351
Comparative Account of Quality Management and Regulatory Aspects of Products with Health Claims: Existing Approaches and Future Challenges for Probiotics and Herbal Products
Drug and Cosmetic Amendment Bill in India: A Promising Hope for Healthy Medical Device Regulatory Environment
, 2(3): 133 - 136Dimple Chaudhary, Swagat Tripathy and Harish Dureja
DOI: 10.2174/2213476X02666150908210025
Drug and Cosmetic Amendment Bill in India: A Promising Hope for Healthy Medical Device Regulatory Environment
Regulations of Cosmetics Across the Globe
, 2(3): 137 - 144Shivaji Rai, Apeksha Gupta and Vikas Punetha
DOI: 10.2174/2213476X03666151125220117
Product Life Cycle Management for Pharmaceutical Innovation
, 2(3): 145 - 152Swagat Tripathy, Vandana Prajapati and VijayaKumar Sengodan Guruswamy
DOI: 10.2174/2213476X03666160112001136
Product Life Cycle Management for Pharmaceutical Innovation
Anti-Monopoly and Competition Laws - Impact on the Indian Pharmaceutical Industry
, 2(3): 153 - 157Prerna Kaushik, Swagat Tripathy, Rishi Sharma and Harish Dureja
DOI: 10.2174/2213476X0203160219101526
Anti-Monopoly and Competition Laws - Impact on the Indian Pharmaceutical Industry
Regulatory Overview of Biosimilars: Current Scenario and Future Opportunities
, 2(3): 158 - 164Ajmer S. Grewal, Viney Lather, Shashikant Bhardwaj and Deepti Pandita
DOI: 10.2174/2213476X03666151221210747
Regulatory Overview of Biosimilars: Current Scenario and Future Opportunities
Good Manufacturing Practice Regulations for Probiotic Based Pharmaceuticals: Current Scenario and Suggestive Recommendations
, 2(3): 165 - 175Malika Arora and Ashish Baldi
DOI: 10.2174/2213476X03666160127001910
Good Manufacturing Practice Regulations for Probiotic Based Pharmaceuticals: Current Scenario and Suggestive Recommendations
Enhanced Globalization and Speed to Market for Innovative Medicines
, 2(3): 176 - 185Leticia Delgado-Herrera, Natalie Boone, Judy Kannenberg, Marcel van Gelderen, Keiichirou Ogawa, Mary Beth Blauwet, Marlowe J Schneidkraut, Sabine Agena, Raymond van Aarle, Yosuke Kubota, Marjan van der Werf-Pieters, Ivanka Baaij and Salim Mujais
DOI: 10.2174/2213476X03666160127001615
Enhanced Globalization and Speed to Market for Innovative Medicines
   |
Editor-in-Chief
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Applied Clinical Research, Clinical Trials and Regulatory Affairs was introduced in 2004 with the assistance of Dr. Satish C. Nair, who is the current Editor-in-Chief serving since 2004.
Webmaster Contact: info@benthamscience.net